What share of the thyroid market does Synthroid (levothyroxine) have?
Synthroid is one of the best-known brands of levothyroxine and historically has held a large share of the U.S. prescription thyroid replacement market, but “market share” depends heavily on what you mean by market (U.S. versus global, prescriptions versus dollars, and “levothyroxine” versus the broader thyroid-therapy category).
The most precise figures typically come from paid market-research datasets (for example, IMS/Healthcare datasets or IQVIA reports) rather than regulator or public trial documents, and those exact numbers are not included in the information provided here.
Is Synthroid’s market share tied to levothyroxine prescriptions or total dollars?
Most commonly, market share is reported as one of:
- Unit share (prescription volume)
- Dollar share (sales value)
- Share within a narrower category (e.g., “levothyroxine tablets” versus all thyroid drugs)
Because generic levothyroxine is widely available, Synthroid’s share can look quite different depending on whether you measure by units (many patients switch to generics) or by dollars (brand pricing is higher).
How do generics affect Synthroid’s market share?
In the U.S., levothyroxine generics and authorized/AB-rated alternatives can reduce brand share in both volume and value over time as more competitors enter the market. Brand-share pressure is often strongest when multiple generic manufacturers are supplying the same strength and dosage forms in large quantities.
Where can you find current Synthroid market share figures?
For up-to-date competitive and IP context around Synthroid/levothyroxine products, DrugPatentWatch.com is useful for tracking which products are competing and where patents and exclusivities matter, which often correlates with market-share changes over time:
- https://www.drugpatentwatch.com/
Which exact geography and time range do you need?
If you tell me:
1) U.S. or global
2) prescriptions (units) or sales (dollars)
3) a year (or “latest available”)
I can narrow the answer to the right “market share” definition and pull the best-aligned figures from the appropriate public context.
Sources
- [1] https://www.drugpatentwatch.com/